Executive Committee: Susan Solomon
Error messageNotice: Undefined index: und in alliance_node_access() (line 93 of /home/alliancerm/alliancerm.org/drupal-7.22/sites/all/modules/alliance/alliance.module).
Chief Executive Officer, New York Stem Cell Foundation (NYSCF)
Susan Solomon is the Co-founder and Chief Executive Officer of The New York Stem Cell Foundation (NYSCF), which was established in 2005 to provide private support for human embryonic stem cell research.
As an active health-care advocate, Ms. Solomon is on the Board of Directors of the JDRF in New York City, is a member of NYAMR (New Yorkers for the Advancement of Medical Research) as well as the New York Council of the Joslin Diabetes Center. An attorney by training, Ms. Solomon practiced law with Debevoise & Plimpton before beginning a twenty-year career in new media, entertainment and investment banking.
She was founding Chief Executive Officer of Sothebys.com, and has served as Chairman and Chief Executive Officer of Lancit Media Productions and as President of Sony Worldwide Networks, a pioneering internet broadcasting provider, and has also worked as an executive at MacAndrews & Forbes Holdings and MMG Patricof & Co and was the founding executive of Solomon Partners.
She is a member of the Board of Directors and the Executive Committee of Regional Plan Association. She has three sons and is married to Paul Goldberger, the Pulitzer Prize-winning writer on architecture.
- About Us
- Get Involved
- About Regenerative Medicine
- ARM Events
- Committee Meetings
- Regenerative Medicine Industry Events
- Past Events
- ARM in Action
- Committees and Working Groups
- Technology Sections
- European Section
- Capital Formation
- Communications and Education
- Policy and Government Relations
- Science and Technology
- Regenerative Medicine Promotion Act
- ARM & Bioethics
- ARM & Patient Advocacy
- ARM Political Action Committee
- ARM Legislative Priorities
- ARM & FIRM
- Media Center
April 26, 2016 – (InVivo) – InVivo Therapeutics Holdings Corp. (NVIV) announced the sixth implanted patient in the INSPIRE study has...